Patents by Inventor Rebecca Lee Ingram

Rebecca Lee Ingram has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABLE AQUEOUS ANTIBODY FORMULATION
    Publication number: 20210128729
    Abstract: The present invention relates to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by an aqueous formulation of an anti-vascular endothelial growth factor (VEGF) antibody.
    Type: Application
    Filed: January 6, 2021
    Publication date: May 6, 2021
    Applicant: PFIZER INC.
    Inventors: REBECCA LEE INGRAM, SARAH ELIZABETH WEISER
  • Stable aqueous anti-vascular endothelial growth factor (VEGF) antibody formulation
    Patent number: 10894083
    Abstract: The present invention relates to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by an aqueous formulation of an anti-vascular endothelial growth factor (VEGF) antibody.
    Type: Grant
    Filed: January 20, 2016
    Date of Patent: January 19, 2021
    Assignee: Pfizer Inc.
    Inventors: Rebecca Lee Ingram, Sarah Elizabeth Weiser
  • STABLE AQUEOUS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) ANTIBODY FORMULATION
    Publication number: 20180000933
    Abstract: The present invention relates to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by an aqueous formulation of an anti-vascular endothelial growth factor (VEGF) antibody.
    Type: Application
    Filed: January 20, 2016
    Publication date: January 4, 2018
    Applicant: Pfizer Inc.
    Inventors: Rebecca Lee Ingram, Sarah Elizabeth Weiser